Literature DB >> 26848601

The Critical Role of Pulmonary Arterial Compliance in Pulmonary Hypertension.

Thenappan Thenappan1, Kurt W Prins1, Marc R Pritzker1, John Scandurra2, Karl Volmers2, E Kenneth Weir1.   

Abstract

The normal pulmonary circulation is a low-pressure, high-compliance system. Pulmonary arterial compliance decreases in the presence of pulmonary hypertension because of increased extracellular matrix/collagen deposition in the pulmonary arteries. Loss of pulmonary arterial compliance has been consistently shown to be a predictor of increased mortality in patients with pulmonary hypertension, even more so than pulmonary vascular resistance in some studies. Decreased pulmonary arterial compliance causes premature reflection of waves from the distal pulmonary vasculature, leading to increased pulsatile right ventricular afterload and eventually right ventricular failure. Evidence suggests that decreased pulmonary arterial compliance is a cause rather than a consequence of distal small vessel proliferative vasculopathy. Pulmonary arterial compliance decreases early in the disease process even when pulmonary artery pressure and pulmonary vascular resistance are normal, potentially enabling early diagnosis of pulmonary vascular disease, especially in high-risk populations. With the recognition of the prognostic importance of pulmonary arterial compliance, its impact on right ventricular function, and its contributory role in the development and progression of distal small-vessel proliferative vasculopathy, pulmonary arterial compliance is an attractive target for the treatment of pulmonary hypertension.

Entities:  

Keywords:  heart failure; impedance; resistance; right ventricle; stiffness

Mesh:

Year:  2016        PMID: 26848601      PMCID: PMC5461956          DOI: 10.1513/AnnalsATS.201509-599FR

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  76 in total

1.  Pulmonary Arterial Capacitance Is an Important Predictor of Mortality in Heart Failure With a Preserved Ejection Fraction.

Authors:  Nadine Al-Naamani; Ioana R Preston; Jessica K Paulus; Nicholas S Hill; Kari E Roberts
Journal:  JACC Heart Fail       Date:  2015-06       Impact factor: 12.035

2.  Decreased time constant of the pulmonary circulation in chronic thromboembolic pulmonary hypertension.

Authors:  Robert V MacKenzie Ross; Mark R Toshner; Elaine Soon; Robert Naeije; Joanna Pepke-Zaba
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-05-17       Impact factor: 4.733

3.  Aortic stiffness is an independent predictor of fatal stroke in essential hypertension.

Authors:  Stéphane Laurent; Sandrine Katsahian; Céline Fassot; Anne-Isabelle Tropeano; Isabelle Gautier; Brigitte Laloux; Pierre Boutouyrie
Journal:  Stroke       Date:  2003-04-03       Impact factor: 7.914

4.  Evaluation of methods for estimation of total arterial compliance.

Authors:  N Stergiopulos; J J Meister; N Westerhof
Journal:  Am J Physiol       Date:  1995-04

5.  Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy.

Authors:  Mariëlle C van de Veerdonk; Taco Kind; J Tim Marcus; Gert-Jan Mauritz; Martijn W Heymans; Harm-Jan Bogaard; Anco Boonstra; Koen M J Marques; Nico Westerhof; Anton Vonk-Noordegraaf
Journal:  J Am Coll Cardiol       Date:  2011-12-06       Impact factor: 24.094

6.  Pulmonary capillary wedge pressure augments right ventricular pulsatile loading.

Authors:  Ryan J Tedford; Paul M Hassoun; Stephen C Mathai; Reda E Girgis; Stuart D Russell; David R Thiemann; Oscar H Cingolani; James O Mudd; Barry A Borlaug; Margaret M Redfield; David J Lederer; David A Kass
Journal:  Circulation       Date:  2011-11-30       Impact factor: 29.690

7.  Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension.

Authors:  Syed H E Zaidi; Xiao-Mang You; Sorana Ciura; Mansoor Husain; Marlene Rabinovitch
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

8.  SC-39026, a serine elastase inhibitor, prevents muscularization of peripheral arteries, suggesting a mechanism of monocrotaline-induced pulmonary hypertension in rats.

Authors:  R Ilkiw; L Todorovich-Hunter; K Maruyama; J Shin; M Rabinovitch
Journal:  Circ Res       Date:  1989-04       Impact factor: 17.367

9.  High pulsatility flow stimulates smooth muscle cell hypertrophy and contractile protein expression.

Authors:  Devon Scott; Yan Tan; Robin Shandas; Kurt R Stenmark; Wei Tan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-10-19       Impact factor: 5.464

10.  Pulmonary vascular wall stiffness: An important contributor to the increased right ventricular afterload with pulmonary hypertension.

Authors:  Zhijie Wang; Naomi C Chesler
Journal:  Pulm Circ       Date:  2011 Apr-Jun       Impact factor: 3.017

View more
  57 in total

1.  Transglutaminase 2 in pulmonary and cardiac tissue remodeling in experimental pulmonary hypertension.

Authors:  Krishna C Penumatsa; Deniz Toksoz; Rod R Warburton; Mousa Kharnaf; Ioana R Preston; Navin K Kapur; Chaitan Khosla; Nicholas S Hill; Barry L Fanburg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-03       Impact factor: 5.464

2.  Abnormal pulmonary flow is associated with impaired right ventricular coupling in patients with COPD.

Authors:  Ani Oganesyan; Alexander Hoffner-Heinike; Alex J Barker; Benjamin S Frank; D Dunbar Ivy; Kendall S Hunter; Max B Mitchell; Stephen M Humphries; Brett E Fenster; Michal Schäfer
Journal:  Int J Cardiovasc Imaging       Date:  2021-05-21       Impact factor: 2.357

3.  Arterial stiffness induces remodeling phenotypes in pulmonary artery smooth muscle cells via YAP/TAZ-mediated repression of cyclooxygenase-2.

Authors:  Paul B Dieffenbach; Christina Mallarino Haeger; Anna Maria F Coronata; Kyoung Moo Choi; Xaralabos Varelas; Daniel J Tschumperlin; Laura E Fredenburgh
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-06-22       Impact factor: 5.464

4.  The prognostic significance of pulmonary arterial capacitance in pulmonary arterial hypertension: single-center experience.

Authors:  Nadine Al-Naamani; Ioana R Preston; Nicholas S Hill; Kari E Roberts
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

5.  Proximal pulmonary vascular stiffness as a prognostic factor in children with pulmonary arterial hypertension.

Authors:  Richard M Friesen; Michal Schäfer; D Dunbar Ivy; Steven H Abman; Kurt Stenmark; Lorna P Browne; Alex J Barker; Kendall S Hunter; Uyen Truong
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2019-02-01       Impact factor: 6.875

6.  Diabetes Mellitus Associates with Increased Right Ventricular Afterload and Remodeling in Pulmonary Arterial Hypertension.

Authors:  Morgan E Whitaker; Vineet Nair; Shripad Sinari; Parinita A Dherange; Balaji Natarajan; Lindsey Trutter; Evan L Brittain; Anna R Hemnes; Eric D Austin; Kumar Patel; Stephen M Black; Joe G N Garcia; Jason X Yuan Md PhD; Rebecca R Vanderpool; Franz Rischard; Ayako Makino; Edward J Bedrick; Ankit A Desai
Journal:  Am J Med       Date:  2018-02-05       Impact factor: 4.965

7.  Pulmonary pulse wave transit time is associated with right ventricular-pulmonary artery coupling in pulmonary arterial hypertension.

Authors:  Kurt W Prins; E Kenneth Weir; Stephen L Archer; Jeremy Markowitz; Lauren Rose; Marc Pritzker; Richard Madlon-Kay; Thenappan Thenappan
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

8.  WIPI1 is a conserved mediator of right ventricular failure.

Authors:  Christos Tzimas; Christoph D Rau; Petra E Buergisser; Gaston Jean-Louis; Katherine Lee; Jeffrey Chukwuneke; Wen Dun; Yibin Wang; Emily J Tsai
Journal:  JCI Insight       Date:  2019-04-25

Review 9.  Can intestinal microbiota and circulating microbial products contribute to pulmonary arterial hypertension?

Authors:  Thenappan Thenappan; Alexander Khoruts; Yingjie Chen; E Kenneth Weir
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-09-06       Impact factor: 4.733

10.  Pulmonary arterial capacitance predicts outcomes in patients with pulmonary hypertension independent of race/ethnicity, sex, and etiology.

Authors:  Jacob J Mayfield; Alexander Papolos; Elena Vasti; Teresa De Marco; Geoffrey H Tison
Journal:  Respir Med       Date:  2020-02-04       Impact factor: 3.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.